Search - tctmd.com

Displaying 61 - 80 of 389

Sort: Relevancy | Date

News Conference News TCT 2016

Novel Method of Softening Hard CTO Plaque May Ease Procedural Difficulties

Yael L. Maxwell

November 02, 2016

Presentation TCT 2016

The TCT 2016 Innovation Award Competition: Session Highlights and Winners Announcement

Presenter: Juan F. Granada, Grzegorz L. Kaluza

November 02, 2016

News Conference News TCT 2016

TCT Mock Election: And the Winner Is...

Shelley Wood

November 02, 2016

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

Todd Neale

November 02, 2016

News Conference News TCT 2016

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

Cerebral Embolic Protection II: The Keystone Deflector - Design Features and Updates From Deflect III and Reflect Clinical Trials

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Andreas Baumbach

November 01, 2016

Presentation TCT 2016

Cerebral Embolic Protection I: The Sentinel Filter - Design Features and Updates from CLEAN-TAVI, SENTINEL RCT, and Others

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Axel Linke

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: PARTNER I 5-YEAR Echo and PARTNER II Quality of Life

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Ganesh Manoharan

November 01, 2016

Presentation TCT 2016

Transfemoral Large Hole Closure Devices: Manta, Inseal, and Others

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Alexandre Abizaid

November 01, 2016

Presentation TCT 2016

Reimbursement Challenges For LAAC: Balancing The Clinical Need Vs. Robust Data Vs. Societal Economic Considerations

Presenter: Aaron V. Kaplan, Rachel Neubrander, Tamara Syrek Jensen

November 01, 2016

Presentation TCT 2016

New Valvuloplasty Devices III: Bard TRUE and TRUE-Flow Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Cheng-Han Chen

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives

Presenter: Aaron V. Kaplan, Rachel Neubrander, Brian K. Whisenant

November 01, 2016

Presentation TCT 2016

New Valvuloplasty Devices II: InterValve V8 Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Wesley R. Pedersen

November 01, 2016

Presentation TCT 2016

New Valvuloplasty Devices I: Pi-cardia Leaflex Aortic Valve Remodeling Therapy

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Michael Jonas

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: SENTINEL

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Alexandra J. Lansky

November 01, 2016

Presentation TCT 2016

Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions What FDA Would Like to See

Presenter: Aaron V. Kaplan, Rachel Neubrander, Katherine Wallon

November 01, 2016

Presentation TCT 2016

Surveying the Global Landscape of TAVR Newcomers

Presenter: Ganesh Manoharan, Hendrik Treede, Martin B. Leon

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: ReACT

Presenter: Giulio Guagliumi, Ik-Kyung Jang, Niels R. Holm

November 01, 2016

Advertisement

Novel Method of Softening Hard CTO Plaque May Ease Procedural Difficulties

The TCT 2016 Innovation Award Competition: Session Highlights and Winners Announcement

TCT Mock Election: And the Winner Is...

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Cerebral Embolic Protection II: The Keystone Deflector - Design Features and Updates From Deflect III and Reflect Clinical Trials

Cerebral Embolic Protection I: The Sentinel Filter - Design Features and Updates from CLEAN-TAVI, SENTINEL RCT, and Others

Highlights (and my Interpretations) From: PARTNER I 5-YEAR Echo and PARTNER II Quality of Life

Transfemoral Large Hole Closure Devices: Manta, Inseal, and Others

Reimbursement Challenges For LAAC: Balancing The Clinical Need Vs. Robust Data Vs. Societal Economic Considerations

New Valvuloplasty Devices III: Bard TRUE and TRUE-Flow Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives

New Valvuloplasty Devices II: InterValve V8 Balloon Valvuloplasty - Technical Advantages and Clinical Applications

New Valvuloplasty Devices I: Pi-cardia Leaflex Aortic Valve Remodeling Therapy

Highlights (and my Interpretations) From: SENTINEL

Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions What FDA Would Like to See

Surveying the Global Landscape of TAVR Newcomers

Highlights (and my Interpretations) From: ReACT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content